Obsidian Therapeutics Inc

NAS:OBXHealth Technologynasdaq_composite

$11.94+1.44%At closeAt close · Tue 20 Oct · ≈ AED 43.85 · Market cap $737.57M · Next earnings Tue 17 Nov

USD millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Depreciation & amortization	0.4	0.8	0.1	0.3	0.0	0.0	—	—
Change in working capital	3.9	(2.6)	0.0	(2.9)	(2.1)	(0.7)	—	—
Operating cash flow	(59.5)	(68.0)	(43.4)	(44.8)	(12.1)	(6.0)	(3.2)	+46.6%
Capital expenditure	(0.5)	(0.3)	(0.0)	(0.1)	0.0	0.0	0.0	—
Dividends paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	—
Free cash flow	(60.0)	(68.2)	(43.5)	(44.9)	(12.1)	(6.0)	(49.6)	−720.6%

USD millionsUpdated Fri 28 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.